Moleculin Biotech Inc. (MBRX) Business News Sept. 09, 2025, 12:46 UTC Moleculin Accelerates Recruitment in Phase 3 Acute Myeloid Leukemia "MIRACLE" Clinical Trial Full text
There are no comments here yet...